The stages of chronic hepatitis B infection has been given a makeover. Is it time for Hep B Bear to move aside?
On International Nurses Day, Hepatitis SA acknowledges the wonderful work of South Australia's viral hepatitis nurses - the skilled, friendly interface between the community and the specialists.
The Phamarceutical Benefits Advisory Committee has recommended the listing of tenofovir alafenamide (TAF) for the treatment of chronic hepatitis B.
If we look at the skills that are helpful in developing emotional strength and at how to deal with the flip side - corrosive attitudes, we can start to develop a stepped approach to better health.
As Australians with hepatitis C are being cured at unprecedented rates, those living with hepatitis B are looking forward to a new treatment which promises the same efficacy as current drugs but with less toxic side effects.
The Pharmaceutical Benefits Scheme (PBS) and the Gastroenterological Society of Australia (GESA) have published information for health professionals to help them manage the new hepatitis C treatments.
This article has been updated to include the new hepatitis C treatment consensus guidelines from January 2017.
South Australian hepatitis B community education projects are but a small selection of the 40 projects progressively being implemented Australia-wide.
Understanding hepatitis A, B and C may not be quite as simple as ABC, but a session with Hepatitis SA's highly skilled educators will certainly help you get there.
Guide to South Australian community pharmacies which dispense the new hepatitis C medicines.
Hepatitis SA is a non-profit, community-based organisation that provides information, education and support services to South Australians affected by hepatitis B and hepatitis C. This includes people with hepatitis B or C, their family and friends, and professionals who support them. We also provide hepatitis C and clean needle program (CNP) peer education and support services, and operate a CNP secondary site.